Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing-remitting multiple sclerosis: 2-year results from the COGIMUS study - Patti, F; Amato, M P; Bastianello, S (Ther Adv Neurol Dis, 2009)
et al.